Diametric Capital’s Parabilis Medicines PBLS Stock Holding History
Bought
Maintained
Sold
Other funds holding PBLS
SL
Diametric Capital's PBLS Position: Q3 2026 in Review
Diametric Capital opened a new position in Parabilis Medicines (PBLS) in Q3 2026: 7,448 shares worth $240K. The stake represents 0.02% of the portfolio and ranks #477 among its holdings.
127 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.
- Diametric Capital held 7,448 shares of Parabilis Medicines worth $240K as of Q3 2026.
- Parabilis Medicines was a new Diametric Capital position in Q3 2026.
- Parabilis Medicines made up 0.02% of Diametric Capital's portfolio in Q3 2026, its #477 holding.
- 127 funds tracked by Wall St. Rank held Parabilis Medicines as of Q3 2026.
Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.